Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3257)
All Articles published online
|
Feb 15, 2001 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Ye SL. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 2001; 7(1): 28-32 [PMID: 11819728 DOI: 10.3748/wjg.v7.i1.28] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i1/28.htm |
| Number | Citing Articles |
| 1 |
Fu-Hua Yan, Kang-Rong Zhou, Jie-Min Cheng, Jian-Hua Wang, Zhi-Ping Yan, Reng-Rong Da, Jia Fan, Yuan Ji. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World Journal of Gastroenterology 2002; 8(4): 658-662 doi: 10.3748/wjg.v8.i4.658
|
| 2 |
Tameyoshi Yamamoto, Hiroaki Nagano, Masato Sakon, Hisashi Wada, Hidetoshi Eguchi, Motoi Kondo, Bazarragchaa Damdinsuren, Hideo Ota, Masato Nakamura, Hiroshi Wada, Shigeru Marubashi, Atsushi Miyamoto, Keizo Dono, Koji Umeshita, Shoji Nakamori, Hideo Yagita, Morito Monden. Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma. Clinical Cancer Research 2004; 10(23): 7884 doi: 10.1158/1078-0432.CCR-04-0794
|
| 3 |
James M. Kiely, William S. Rilling, John G. Touzios, Robert A. Hieb, Jose Franco, Kia Saeian, Edward J. Quebbeman, Henry A. Pitt. Chemoembolization in Patients at High Risk: Results and Complications. Journal of Vascular and Interventional Radiology 2006; 17(1): 47 doi: 10.1097/01.RVI.0000195074.43474.2F
|
| 4 |
Zhao-Chong Zeng, Guo-Liang Jiang, Guo-Min Wang, Zhao-You Tang, Walter J. Curran, George Iliakis. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World Journal of Gastroenterology 2002; 8(5): 797-803 doi: 10.3748/wjg.v8.i5.797
|
| 5 |
Laura Marelli, Rosa Stigliano, Christos Triantos, Marco Senzolo, Evangelos Cholongitas, Neil Davies, Jonathan Tibballs, Tim Meyer, David W. Patch, Andrew K. Burroughs. Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies. CardioVascular and Interventional Radiology 2007; 30(1): 6 doi: 10.1007/s00270-006-0062-3
|
| 6 |
Gao-Quan Gong, Xiao-Lin Wang, Jian-Hua Wang, Zhi-Ping Yan, Jie-Min Cheng, Sheng Qian, Yi Chen. Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients. World Journal of Gastroenterology 2001; 7(6): 880-883 doi: 10.3748/wjg.v7.i6.880
|
| 7 |
Yang Gao, Peng‐Xiang Wang, Jian‐Wen Cheng, Yun‐Fan Sun, Bo Hu, Wei Guo, Kai‐Qian Zhou, Yue Yin, Yuan‐Cheng Li, Jian Wang, Jun‐Feng Huang, Shuang‐Jian Qiu, Jian Zhou, Jia Fan, Xin‐Rong Yang. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis. Cancer Medicine 2019; 8(16): 6933 doi: 10.1002/cam4.2556
|
| 8 |
Zhong-Jie Sun, Cheng-En Pan, Hong-Shan Liu, Guo-Jun Wang. Anti-hepatoma activity of resveratrol <italic>in vitro</italic>. World Journal of Gastroenterology 2002; 8(1): 79-81 doi: 10.3748/wjg.v8.i1.79
|
| 9 |
Andrea Ruzzenente, Franco Capra, Silvia Pachera, Calogero Iacono, Gianluca Piccirillo, Marta Lunardi, Stefano Pistoso, Alessandro Valdegamberi, Mirko D’Onofrio, Alfredo Guglielmi. Is Liver Resection Justified in Advanced Hepatocellular Carcinoma? Results of an Observational Study in 464 Patients. Journal of Gastrointestinal Surgery 2009; 13(7): 1313 doi: 10.1007/s11605-009-0903-x
|
| 10 |
Bao-Gang Peng, Qiang He, Jia-Ping Li, Fan Zhou. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. The American Journal of Surgery 2009; 198(3): 313 doi: 10.1016/j.amjsurg.2008.09.026
|
| 11 |
Qing-Yu Liu, Wei-Dong Zhang, Jian-Yu Chen, Hai-Gang Li, Chao Liu, Bi-Ling Liang. Hepatocellular Carcinoma With Bile Duct Tumor Thrombus. Journal of Computer Assisted Tomography 2011; 35(2): 187 doi: 10.1097/RCT.0b013e3182067f2e
|
| 12 |
Dao-Xiong Lei, Cheng-Hong Peng, Shu-You Peng, Xian-Chuan Jiang, Yu-Lian Wu, Hong-Wei Shen. Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats. World Journal of Gastroenterology 2001; 7(5): 713-717 doi: 10.3748/wjg.v7.i5.713
|
| 13 |
Tameyoshi Yamamoto, Hiroaki Nagano, Yasuharu Imai, Kazuto Fukuda, Hitoshi Matsumoto, Motoi Kondo, Hideo Ota, Masato Nakamura, Hiroshi Wada, Takehiro Noda, Bazarragchaa Damdinsuren, Keizo Dono, Koji Umeshita, Shoji Nakamori, Masato Sakon, Kenichi Wakasa, Morito Monden. Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy. International Journal of Clinical Oncology 2007; 12(2): 150 doi: 10.1007/s10147-006-0630-1
|
| 14 |
Wu Ji, Jie-Shou Li, Ling-Tang Li, Wu-Hong Liu, Kuan-Sheng Ma, Xiang-Tian Wang, Zhen-Ping He, Jia-Hong Dong. Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(8): 1702-1706 doi: 10.3748/wjg.v9.i8.1702
|
| 15 |
Masato Nakamura, Hiroaki Nagano, Masato Sakon, Tameyoshi Yamamoto, Hideo Ota, Hiroshi Wada, Bazarragchaa Damdinsuren, Takehiro Noda, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Shoji Nakamori, Keizo Dono, Morito Monden. Role of the Fas/FasL pathway in combination therapy with interferon-α and fluorouracil against hepatocellular carcinoma in vitro. Journal of Hepatology 2007; 46(1): 77 doi: 10.1016/j.jhep.2006.07.032
|
| 16 |
Zheng-Xu Wang, Gui-Fang Hu, Hong-Yang Wang, Meng-Chao Wu. Expression of liver cancer associated gene HCCA3. World Journal of Gastroenterology 2001; 7(6): 821-825 doi: 10.3748/wjg.v7.i6.821
|
| 17 |
Xue‐Bin Zhang, Jian‐Hua Wang, Zhi‐Pin Yan, Sheng Qian, Shi‐Suo Du, Zhao‐Chong Zeng. Hepatocellular carcinoma with main portal vein tumor thrombus. Cancer 2009; 115(6): 1245 doi: 10.1002/cncr.24139
|
| 18 |
Fumihiko Fujita, Susumu Eguchi, Yoshitsugu Tajima, Takashi Kanematsu. Minimally Invasive Surgical Oncology. 2011; : 263 doi: 10.1007/978-3-540-45021-4_21
|
| 19 |
Kenneth S. Chok, Kenneth C. Ng, Chi Ming Lam, Kelvin K. Ng, Ronnie T. Poon, Sheung Tat Fan. Selective Portal Vein Clamping for Radiofrequency Ablation of Hepatocellular Carcinoma With Portal Vein Invasion. Journal of Gastrointestinal Surgery 2005; 9(4): 489 doi: 10.1016/j.gassur.2004.09.056
|
| 20 |
Mohamed A S Kohla, Mai I Abu Zeid, Mohamed Al-Warraky, Hossam Taha, Robert G Gish. Predictors of hepatic decompensation after TACE for hepatocellular carcinoma. BMJ Open Gastroenterology 2015; 2(1): e000032 doi: 10.1136/bmjgast-2015-000032
|
| 21 |
Wen-Jiao Zeng, Guo-Yuan Liu, Jie Xu, Xin-Da Zhou, Yue-E Zhang, Nong Zhang. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(6): 1040-1044 doi: 10.3748/wjg.v8.i6.1040
|
| 22 |
Jiongjie Yu, Li Zhuang, Peng Liu, Zhikun Liu, Sunbin Ling, Yinan Deng, Jianhua Li, Bo Yang, Zhishui Chen, Zhengxin Wang, Yunjin Zang, Yang Yang, Shusen Zheng, Xiao Xu. Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter study. European Journal of Surgical Oncology 2022; 48(1): 121 doi: 10.1016/j.ejso.2021.08.014
|
| 23 |
Georgios C. Sotiropoulos, Arnold Radtke, Klaus J. Schmitz, Ernesto P. Molmenti, Tobias Schroeder, Fuat H. Saner, Hideo A. Baba, Ioannis Fouzas, Christoph E. Broelsch, Massimo Malagó, Hauke Lang. Liver Transplantation in the Setting of Hepatocellular Carcinoma and Portal Vein Thrombosis: A Challenging Dilemma?. Digestive Diseases and Sciences 2008; 53(7): 1994 doi: 10.1007/s10620-007-0099-4
|
| 24 |
Alessandra Borgheresi, Anne Covey, Hooman Yarmohammadi, Franz E. Boas, Etay Ziv, George Getrajdman, Joseph Erinjeri, William Jarnagin, James J. Harding, Michael D'Angelica, Mithat Gonen, Karen T. Brown. Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progression. HPB 2020; 22(4): 588 doi: 10.1016/j.hpb.2019.08.004
|
| 25 |
W.Y. Lau, Simon C.H. Yu, Eric C.H. Lai, Thomas W.T. Leung. Transarterial Chemoembolization for Hepatocellular Carcinoma. Journal of the American College of Surgeons 2006; 202(1): 155 doi: 10.1016/j.jamcollsurg.2005.06.263
|
| 26 |
C.J. YOON, J.W. CHUNG. Surgery of the Liver, Biliary Tract and Pancreas. 2007; : 1218 doi: 10.1016/B978-1-4160-3256-4.50089-2
|
| 27 |
Ming-Sheng Huang, Qu Lin, Zai-Bo Jiang, Kang-Shun Zhu, Shou-Hai Guan, Zheng-Ran Li, Hong Shan. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(6): 825-829 doi: 10.3748/wjg.v10.i6.825
|
| 28 |
Satoshi Katagiri, Masakazu Yamamoto. Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surgery Today 2014; 44(2): 219 doi: 10.1007/s00595-013-0585-6
|
| 29 |
Nishita Kothary, Joshua L. Weintraub, Jonathan Susman, John H. Rundback. Transarterial Chemoembolization for Primary Hepatocellular Carcinoma in Patients at High Risk. Journal of Vascular and Interventional Radiology 2007; 18(12): 1517 doi: 10.1016/j.jvir.2007.07.035
|
| 30 |
Xue-Bin Zhang, Jian-Hua Wang, Zhi-Ping Yan, Sheng Qian, Rong Liu. Hepatocellular Carcinoma Invading the Main Portal Vein: Treatment with Transcatheter Arterial Chemoembolization and Portal Vein Stenting. CardioVascular and Interventional Radiology 2009; 32(1): 52 doi: 10.1007/s00270-008-9454-x
|
| 31 |
Jia Fan, Jian Zhou, Zhi-Quan Wu, Shuang-Jian Qiu, Xiao-Ying Wang, Ying-Hong Shi, Zhao-You Tang. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology 2005; 11(8): 1215-1219 doi: 10.3748/wjg.v11.i8.1215
|
| 32 |
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Jian Zhou, Lun-Xiu Qin, Jian-Hua Wang, Hui-Chuan Sun, Bin-Liang Wang, Jian-Ying Zhang, Guo-Liang Jiang, Yu-Qi Wang. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. International Journal of Radiation Oncology*Biology*Physics 2005; 61(2): 432 doi: 10.1016/j.ijrobp.2004.05.025
|
| 33 |
Sascha C. A. Herber, Gerd Otto, Jens Schneider, Markus Schuchmann, Christoph Düber, Michael B. Pitton, Inga Kummer, Nicole Manzl. Transarterial Chemoembolization in Patients Not Eligible for Liver Transplantation: Single-Center Results. American Journal of Roentgenology 2008; 190(4): 1035 doi: 10.2214/AJR.07.2755
|
| 34 |
Q. Li, J. Wang, Y. Sun, Y.L. Cui, J.T. Juzi, H.X. Li, B.Y. Qian, X.S. Hao. Efficacy of Postoperative Transarterial Chemoembolization and Portal Vein Chemotherapy for Patients with Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis—a Randomized Study. World Journal of Surgery 2006; 30(11): 2004 doi: 10.1007/s00268-006-0271-6
|
| 35 |
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Transarterial approaches to primary and secondary hepatic malignancies. Nature Reviews Clinical Oncology 2015; 12(8): 481 doi: 10.1038/nrclinonc.2015.78
|
| 36 |
Rana Ahmed Youness, Mai Atef Rahmoon, Reem Amr Assal, Asmaa Ibrahim Gomaa, Mohamed Tarif Hamza, Imam Waked, Hend Mohamed El Tayebi, Ahmed Ihab Abdelaziz. Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression. Growth Factors 2016; 34(3-4): 128 doi: 10.1080/08977194.2016.1200571
|
| 37 |
Lei Chang, Yitao Wang, Jibo Zhang, Tao Guo. The best strategy for HCC patients at each BCLC stage: a network meta-analysis of observational studies. Oncotarget 2017; 8(12): 20418 doi: 10.18632/oncotarget.14668
|
| 38 |
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver 2021; 15(2): 284 doi: 10.5009/gnl19367
|
| 39 |
Riad Salem, Robert Lewandowski, Carol Roberts, James Goin, Kenneth Thurston, Marwan Abouljoud, Angi Courtney. Use of Yttrium-90 Glass Microspheres (TheraSphere) for the Treatment of Unresectable Hepatocellular Carcinoma in Patients with Portal Vein Thrombosis. Journal of Vascular and Interventional Radiology 2004; 15(4): 335 doi: 10.1097/01.RVI.0000123319.20705.92
|
| 40 |
Kazuhiko Sakamoto, Hiroaki Nagano. Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatology Research 2017; 47(10): 957 doi: 10.1111/hepr.12923
|
| 41 |
Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3895-z
|
| 42 |
Wei Wu, Xin-Bao Lin, Jian-Min Qian, Zhen-Ling Ji, Zao Jiang. Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(4): 763-765 doi: 10.3748/wjg.v8.i4.763
|
| 43 |
Kun Li, Hai-Tao Wang, Yu-Kun He, Tao Guo. New idea for treatment strategies for Barcelona Clinic Liver Cancer stages based on a network meta-analysis. Medicine 2017; 96(20): e6950 doi: 10.1097/MD.0000000000006950
|
| 44 |
En-Hua Xiao, Jing-Qing Li, Jie-Fu Huang. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization. World Journal of Gastroenterology 2004; 10(2): 190-194 doi: 10.3748/wjg.v10.i2.190
|
| 45 |
Derek M. Biederman, Joseph J. Titano, Nora E. Tabori, Elisa S. Pierobon, Kutaiba Alshebeeb, Myron Schwartz, Marcelo E. Facciuto, Ganesh Gunasekaran, Sander Florman, Aaron M. Fischman, Rahul S. Patel, Francis S. Nowakowski, Edward Kim. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres. Journal of Vascular and Interventional Radiology 2016; 27(6): 812 doi: 10.1016/j.jvir.2016.01.147
|
| 46 |
Shuang Wei, Xiaoyi Hao, Daqian Zhan, Min Xiong, Kaiyan Li, Xiaoping Chen, Zhiyong Huang. Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified?. Journal of Huazhong University of Science and Technology [Medical Sciences] 2011; 31(5): 637 doi: 10.1007/s11596-011-0574-1
|
| 47 |
Ming-Yue Luo, Hong Shan, Zai-Bo Jiang, Lu-Fang Li, Hui-Qing Huang. Study on hepatocelluar carcinoma-associated hepatic arteriovenous shunt using multidetector CT. World Journal of Gastroenterology 2003; 9(11): 2455-2459 doi: 10.3748/wjg.v9.i11.2455
|
| 48 |
Luca Tirloni, Ilenia Bartolini, Carlo Gazia, Andrea Scarinci, Gian Luca Grazi. A contemporary view on vascular resections and reconstruction during hepatectomies. Updates in Surgery 2024; 76(5): 1643 doi: 10.1007/s13304-024-01934-z
|
| 49 |
Su Jong Yu, Yoon Jun Kim. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World Journal of Hepatology 2015; 7(11): 1553-1561 doi: 10.4254/wjh.v7.i11.1553
|
| 50 |
Gui-Mei Zhang, Yan Yang, Bo Huang, Hui Xiao, Dong Li, Zuo-Hua Feng. Experimental study on therapeutic effect of <italic>in vivo</italic> expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(9): 1940-1945 doi: 10.3748/wjg.v9.i9.1940
|
| 51 |
Ye Xin Koh, Hwee Leong Tan, Weng Kit Lye, Juinn Huar Kam, Adrian Kah Heng Chiow, Siong San Tan, Su Pin Choo, Alexander Yaw Fui Chung, Brian Kim Poh Goh. Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence. World Journal of Hepatology 2018; 10(6): 433-447 doi: 10.4254/wjh.v10.i6.433
|
| 52 |
Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik. Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice. Journal of Liver Cancer 2023; 23(2): 350 doi: 10.17998/jlc.2023.08.10
|
| 53 |
Yung-Chih Lai, Cheng-Yen Shih, Chin-Ming Jeng, Sien-Sing Yang, Jui-Ting Hu, Yung-Chuan Sung, Han-Ting Liu, Shaw-Min Hou, Chi-Hwa Wu, Tzen-Kwan Chen. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of the portal vein tumor thrombosis. World Journal of Gastroenterology 2003; 9(12): 2666-2670 doi: 10.3748/wjg.v9.i12.2666
|
| 54 |
Lian-Xin Liu, Zhi-Hua Liu, Hong-Chi Jiang, Wei-Hui Zhang, Shu-Yi Qi, Jie Hu, Xiu-Qin Wang, Min Wu. Gene expression profiles of hepatoma cell line HLE. World Journal of Gastroenterology 2003; 9(4): 683-687 doi: 10.3748/wjg.v9.i4.683
|
| 55 |
Yadi Liao, Yun Zheng, Wei He, Qijiong Li, Jingxian Shen, Jian Hong, Ruhai Zou, Jiliang Qiu, Binkui Li, Yunfei Yuan. Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence. Oncology Letters 2017; 13(2): 984 doi: 10.3892/ol.2016.5525
|
| 56 |
Laura M. Kulik, Brian I. Carr, Mary F. Mulcahy, Robert J. Lewandowski, Bassel Atassi, Robert K. Ryu, Kent T. Sato, Al Benson, Albert A. Nemcek, Vanessa L. Gates, Michael Abecassis, Reed A. Omary, Riad Salem. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008; 47(1): 71 doi: 10.1002/hep.21980
|
| 57 |
Yasir M. Nouri, Jin Hyoung Kim, Hyun-Ki Yoon, Heung-Kyu Ko, Ji Hoon Shin, Dong Il Gwon. Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma. Korean Journal of Radiology 2019; 20(1): 34 doi: 10.3348/kjr.2018.0088
|
| 58 |
Douglas E. Ramsey, Lily Y. Kernagis, Michael C. Soulen, Jean-Francois H. Geschwind. Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002; 13(9): S211 doi: 10.1016/S1051-0443(07)61789-8
|